Friday - December 27, 2024

Treatment of Brain Cancers Using Central Nervous System Mediated Gene Transfer of Monoclonal Antibodies

2024-10-22

ALEXANDRIA, Virginia, Oct. 22 -- MEMORIAL SLOAN-KETTERING CANCER CENTER, New York, New York has been assigned a patent (No. US 12122844 B2, initially filed July 13, 2020) developed by four inventors Ronald G. Crystal, New York, New York; Stephen M. Kaminsky, Bronx, New York; Martin J. Hicks, New York, New York; and Viviane Tabar, New York, New York, for "Treatment of brain cancers using central nervous system mediated gene transfer of monoclonal antibodies." . . .

Information Request Form

Name:
Category that best fits the type of business or agency you are affiliated with:	Government Newspaper / Media Business Public Policy Individual / Student Educators
Company Name:
Email:
Phone:
State:

I'd like to have a copy of this article mailed to me.

To also receive a free sample of other Targeted News products check the appropriate boxes below.
Golf Handicap site (FairwayFiles.com)
Products marked with ** can be customized by keywords or areas of interest. If you select them please specify your keywords in the box below:

If we need to contact you please specify your preferred contact method. Have a representative contact me by phone
Have a representative contact me via email

Additonal questions or comments:

Click here for more information or a free trial

Existing Customer Login

Treatment of Brain Cancers Using Central Nervous System Mediated Gene Transfer of Monoclonal Antibodies

Information Request Form

Copyright Targeted News Service 2024